Novartis has announced that its chief executive, Joseph Jimenez, plans...

30 September 2017

Novartis has announced that its chief executive, Joseph Jimenez, plans to step down from the role in January 2018, and to retire from the company on Aug. 31, 2018. Vasant (Vas) Narasimhan, the company's global head of drug development and chief medical officer, has been chosen by Novartis' board of ...

Already an Eyewear Intelligence subscriber? Sign in here.

Subscribe today

Buying a membership today will give you:

Unlimited access to ewintelligence.com - all insight and analysis available online
Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
Case studies and best practices on business challenges
Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
Access to over 11,500 articles and analyses in the archive
Personal library to save articles and track your key content
Powerful search and intuitive navigation
Organisation-wide access across offices, people and devices

SUBSCRIBE TODAY

To continue reading this article register now.